Tiny Heart-Vibration patch could predict surgery risks in oesophageal cancer

NCT ID NCT07159711

Not yet recruiting Knowledge-focused Sponsor: Guy's and St Thomas' NHS Foundation Trust Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests a small device called Seismofit that sticks to the chest and measures heart vibrations to estimate fitness in under three minutes. Researchers want to see if it can predict complications like pneumonia and hospital stay length in 164 oesophageal cancer patients undergoing chemotherapy and surgery. The device is compared to the standard hour-long exercise test to see if it is accurate enough for routine use.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Seismofit device (a small chest patch that measures heart vibrations to estimate fitness)
What this could lead to: If successful, this could provide a quick, simple way to assess fitness and predict complications in oesophageal cancer patients, helping doctors tailor treatment.
What could go wrong: This is an early-stage study with only 164 participants, and the device has not been tested in this patient group before. It may not accurately predict outcomes or replace standard tests.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEOADJUVANT CHEMOTHERAPY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Adenocarcinoma Of Esophagus esophageal adenocarcinoma esophageal cancer Esophageal Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NEOADJUVANT CHEMOTHERAPY OESOPHAGEAL ADENOCARCINOMA OESOPHAGEAL CANCER OESOPHAGECTOMY PREHABILITATION

More trials for these conditions

Other studies related to the condition(s) this trial covers.